» Articles » PMID: 14486208

Cyclophosphamide and Urinary Bladder Toxicity

Overview
Journal Cancer Res
Specialty Oncology
Date 1961 Dec 1
PMID 14486208
Citations 52
Authors
Affiliations
Soon will be listed here.
Citing Articles

Urotoxicity of Cyclophosphamide: A Comparison Across Neoplastic, Autoimmune, and Transplant Indications.

Gu J, Samarneh M Cureus. 2025; 16(12):e75180.

PMID: 39764309 PMC: 11701789. DOI: 10.7759/cureus.75180.


Preliminary proteomic analysis of mouse lung tissue treated with cyclophosphamide and Venetin-1.

Czaplewska P, Muller M, Musial N, Okroj M, Felberg-Mietka A, Sadowska J Sci Rep. 2024; 14(1):25056.

PMID: 39443613 PMC: 11499674. DOI: 10.1038/s41598-024-76143-0.


Hemorrhagic Cystitis: Making Rapid and Shrewd Clinical and Surgical Decisions for Improving Patient Outcomes.

Jefferson F, Linder B Res Rep Urol. 2023; 15:291-303.

PMID: 37404838 PMC: 10317550. DOI: 10.2147/RRU.S320684.


Protective Effect of Low Molecular Weight Peptides from Head against Cyclophosphamide-Induced Nephrotoxicity in Mice the Keap1/Nrf2 Pathway.

Jiang S, Zhang Z, Huang F, Yang Z, Yu F, Tang Y Antioxidants (Basel). 2020; 9(8).

PMID: 32823691 PMC: 7465301. DOI: 10.3390/antiox9080745.


Nonclinical Safety Assessment of AMG 553, an Investigational Chimeric Antigen Receptor T-Cell Therapy for the Treatment of Acute Myeloid Leukemia.

Karbowski C, Goldstein R, Frank B, Kim K, Li C, Homann O Toxicol Sci. 2020; 177(1):94-107.

PMID: 32589753 PMC: 7553704. DOI: 10.1093/toxsci/kfaa098.